133 related articles for article (PubMed ID: 21888567)
1. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia.
Ku NS; Han SH; Kim CO; Baek JH; Jeong SJ; Jin SJ; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2011 Oct; 43(10):792-7. PubMed ID: 21888567
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.
Liao CH; Chang HT; Lai CC; Huang YT; Hsu MS; Liu CY; Yang CJ; Hsueh PR
Diagn Microbiol Infect Dis; 2011 Jun; 70(2):260-6. PubMed ID: 21392926
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of patients with Burkholderia cepacia bacteremia.
Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
[TBL] [Abstract][Full Text] [Related]
4. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates.
Yu WL; Wang DY; Lin CW; Tsou MF
Scand J Infect Dis; 1999; 31(3):293-8. PubMed ID: 10482060
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
[TBL] [Abstract][Full Text] [Related]
6. [Burkholderia cepacia bacteremia: a prospective analysis of 33 episodes].
Pinilla MI; Cobos-Trigueros N; Soriano Á; Martínez JA; Zboromyrska Y; Almela M; Mensa J
Rev Esp Quimioter; 2011 Dec; 24(4):209-12. PubMed ID: 22173191
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
Metan G; Sariguzel F; Sumerkan B
Eur J Intern Med; 2009 Sep; 20(5):540-4. PubMed ID: 19712862
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes.
Song JS; Choe PG; Song KH; Park WB; Park SW; Kim HB; Oh MD; Kim EC; Kim NJ
Epidemiol Infect; 2012 Jul; 140(7):1267-76. PubMed ID: 21906414
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex.
Righi E; Girardis M; Marchegiano P; Venturelli C; Tagliazucchi S; Pecorari M; Borsari L; Carluccio E; Codeluppi M; Mussini C; Aggazzotti G
J Hosp Infect; 2013 Sep; 85(1):73-5. PubMed ID: 23927925
[TBL] [Abstract][Full Text] [Related]
10. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
Baylan O
Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
[TBL] [Abstract][Full Text] [Related]
12. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia.
Ku NS; Kim HW; Oh HJ; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
Shock; 2012 Aug; 38(2):123-7. PubMed ID: 22683729
[TBL] [Abstract][Full Text] [Related]
15. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes.
Lu DC; Chang SC; Chen YC; Luh KT; Lee CY; Hsieh WC
J Formos Med Assoc; 1997 Dec; 96(12):972-8. PubMed ID: 9444917
[TBL] [Abstract][Full Text] [Related]
16. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.
Woods CW; Bressler AM; LiPuma JJ; Alexander BD; Clements DA; Weber DJ; Moore CM; Reller LB; Kaye KS
Clin Infect Dis; 2004 May; 38(9):1243-50. PubMed ID: 15127335
[TBL] [Abstract][Full Text] [Related]
17. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia.
Kwon KT; Oh WS; Song JH; Chang HH; Jung SI; Kim SW; Ryu SY; Heo ST; Jung DS; Rhee JY; Shin SY; Ko KS; Peck KR; Lee NY
J Antimicrob Chemother; 2007 Mar; 59(3):525-30. PubMed ID: 17213265
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia Sepsis in Children as a Hospital-Acquired Infection.
Kim KY; Yong D; Lee K; Kim HS; Kim DS
Yonsei Med J; 2016 Jan; 57(1):97-102. PubMed ID: 26632388
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
